Deep Medicine Acquisition... (DMAQ)
NASDAQ: DMAQ
· Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM
Deep Medicine Acquisition Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -10.93M | -8.53M | -612.16K | -612.16K | -507.38K | -400.23K | 74.02K | -638.75K | -551.97K | -414.05K | -290.09K | -154.67K | -75.89K |
Depreciation & Amortization | 843.49K | 639.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | 3.78M | 3.69M | -874.33K | -1.36M | -1.82M | -1.82M | -1.72M | -663.44K | -111.28K | 4.13K | -2.18K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -410.46K | -318.6K | 797.18K | 973.58K | 1.41M | 1.19M | 878.47K | 415.5K | -201.49K | -287.96K | -318.03K | -31.46K | 61.11K |
Operating Cash Flow | -4.12M | -3.94M | -111.97K | -996.68K | -920.82K | -1.04M | -769.89K | -886.7K | -864.74K | -697.87K | -610.3K | -186.13K | -14.79K |
Capital Expenditures | -100.5K | -36.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 2.48M | 2.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -4.69M | -1.5M | 123.65M | 123.14M | 120.22M | 120.42M | -510.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.31M | 941.14K | 123.65M | 123.14M | 120.22M | 120.42M | -510.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -121.03M | -121.03M | -121.03M | -121.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 39.67M | 34.32M | -111.05M | -122.3M | -119.47M | -119.67M | 1.26M | 128.84M | 128.84M | 128.84M | 129.35M | 512.5K | 512.5K |
Financial Cash Flow | 13.89M | 8.54M | -111.05M | -122.3M | -106.2M | -106.4M | 14.54M | 142.11M | 128.84M | 128.84M | 129.35M | 512.5K | 512.5K |
Net Cash Flow | 12.62M | 10.7M | 12.48M | -157.19K | -165.94K | -281.56K | -15.02K | 188.3K | 210.16K | 377.03K | 977.1K | 326.27K | 497.71K |
Free Cash Flow | -4.22M | -3.98M | -111.97K | -996.68K | -920.82K | -1.04M | -769.89K | -886.7K | -864.74K | -697.87K | -610.3K | -186.13K | -14.79K |